{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T23:36:45Z","timestamp":1782689805828,"version":"3.54.5"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Opioid overdose related injury or death can be prevented by bystander naloxone administration. For naloxone to be present when and where overdoses occur, opioid prevention education and naloxone distribution (OPEND) must be established on a broad level. This is the 30-month follow-up of the first multi-site naloxone project in Sweden, implemented at 31 sites in the County of Sk\u00e5ne 2018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To address participant characteristics and factors associated with returning for naloxone refill and with having used naloxone for overdose reversal. An additional aim was to describe self-reported reasons for naloxone refill and overdose experiences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected during June 2018\u2014December 2020 through questionnaires at baseline and upon naloxone refill of the initial and subsequent naloxone kit. Descriptive statistics was used to address participant characteristics, those returning for naloxone refill and reporting overdose reversal. Chi-2 test was used for variable comparison between groups. Factors associated with overdose reversals were examined by logistic regression analysis. Reasons for naloxone refill, overdose situation and management were presented descriptively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 1,079 study participants, 22% (<jats:italic>n<\/jats:italic> = 235) returned for naloxone refill, of which 60% (<jats:italic>n<\/jats:italic> = 140) reported a total of 229 overdose reversals. Reversals were more likely to be reported by participants trained at needle exchange programs (NEPs) [adjusted odds ratio (AOR) = 5.18, 95% Confidence interval (CI) = 3.38\u20137.95)], with previous experience of own (AOR = 1.63, 95% CI = 1.03\u20132.58) or witnessed (AOR = 2.12, 95% CI = 1.05\u20134.29) overdose, or who had used sedatives during the last 30 days before initial training (AOR = 1.56, 95% CI = 1.04\u20132.33). A majority of overdoses reportedly occurred in private settings (62%), where the victim was a friend (35%) or acquaintance (31%) of the rescuer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Participants with own risk factors associated with overdose (e.g., injection use, concomitant use of benzodiazepines and previous experience of own overdose) were more likely to report administering naloxone for overdose reversal. Overdose management knowledge was high. The findings indicate that implementation of multi-site OPEND reaches individuals at particularly high risk of own overdose in settings with limited previous harm reduction strategies and favors a further scaling up of naloxone programs in similar settings.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.811001","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:15:02Z","timestamp":1646907302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Characteristics of and Experience Among People Who Use Take-Home Naloxone in Sk\u00e5ne County, Sweden"],"prefix":"10.3389","volume":"10","author":[{"given":"Katja","family":"Troberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernilla","family":"Isendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Alanko","family":"Blom\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disa","family":"Dahlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","unstructured":"2021"},{"key":"B2","article-title":"Luxembourg: Publications Office of the European Union","year":"2020"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-019-0137-5","article-title":"Opioid use disorder","volume":"6","author":"Strang","year":"2020","journal-title":"Nat Rev Dis Prim."},{"key":"B4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2013","journal-title":"Int J Epidemiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"Int J Drug Policy."},{"key":"B6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1600-0447.1990.tb03057.x","article-title":"Mortality in heroin addiction: impact of methadone treatment","volume":"82","author":"Gronbladh","year":"1990","journal-title":"Acta Psychiatrica Scandinavica."},{"key":"B7","doi-asserted-by":"publisher","first-page":"Cd002209","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"Cd002207","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2014","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2013tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0227298","DOI":"10.1371\/journal.pone.0227298","article-title":"The effectiveness of substance use interventions for homeless and vulnerably housed persons: a systematic review of systematic reviews on supervised consumption facilities, managed alcohol programs, and pharmacological agents for opioid use disorder","volume":"15","author":"Magwood","year":"2020","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","article-title":"Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review","volume":"14","author":"Kennedy","year":"2017","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B13","unstructured":"2015"},{"key":"B14","unstructured":"2014"},{"key":"B15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/add.13265","article-title":"Effectiveness of scotland's national naloxone programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison","volume":"111","author":"Bird","year":"2016","journal-title":"Addiction."},{"key":"B16","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","article-title":"Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria","volume":"111","author":"McDonald","year":"2016","journal-title":"Addiction."},{"key":"B18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1360-0443.2008.02182.x","article-title":"Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States","volume":"103","author":"Green","year":"2008","journal-title":"Addiction."},{"key":"B19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1046\/j.1360-0443.1999.9444712.x","article-title":"Self-reported overdose among injecting drug users in London: extent and nature of the problem","volume":"94","author":"Powis","year":"1999","journal-title":"Addiction."},{"key":"B20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1360-0443.1999.9421993.x","article-title":"Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability","volume":"94","author":"Strang","year":"1999","journal-title":"Addiction."},{"key":"B21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.drugalcdep.2005.01.010","article-title":"Circumstances of witnessed drug overdose in New York City: implications for intervention","volume":"79","author":"Tracy","year":"2005","journal-title":"Drug Alcohol Dep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.drugalcdep.2011.07.018","article-title":"Characteristics of drug users who witness many overdoses: implications for overdose prevention","volume":"120","author":"Bohnert","year":"2012","journal-title":"Drug Alcohol Dep."},{"key":"B23","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons - United States, 2014","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR."},{"key":"B24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1177\/0002716202058002005","article-title":"Swedish drug policy in the twenty-first century: a policy model going astray","volume":"582","author":"Lenke","year":"2002","journal-title":"Ann Am Acad Polit Soc Sci."},{"key":"B25","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/1455072520965013","article-title":"Could 30 years of political controversy on needle exchange programmes in Sweden contribute to scaling-up harm reduction services in the world?","volume":"38","author":"Karlsson","year":"2020","journal-title":"Nordic Stud Alcohol Drugs."},{"key":"B26","unstructured":"2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843a","article-title":"Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"Am J Public Health."},{"key":"B28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","article-title":"A systematic review of community opioid overdose prevention and naloxone distribution programs","volume":"8","author":"Clark","year":"2014","journal-title":"J Addict Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/02791072.2018.1430409","article-title":"From peers to lay bystanders: findings from a decade of naloxone distribution in Pittsburgh, PA","volume":"50","author":"Bennett","year":"2018","journal-title":"J Psychoact Drugs."},{"key":"B30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12954-019-0328-0","article-title":"One opioid user saving another: the first study of an opioid overdose-reversal and naloxone distribution program addressing hard-to-reach drug scenes in Denmark","volume":"16","author":"Thylstrup","year":"2019","journal-title":"Harm Red J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/add.12961","article-title":"Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program","volume":"110","author":"Rowe","year":"2015","journal-title":"Addiction."},{"key":"B32","unstructured":"2019"},{"key":"B33","volume-title":"[National Board of Health and Welfare]. SFS 2006:323. Lag om Utbyte av Sprutor Och Kanyler. [Code of statues (SFS 2006:323 regulating exchange of syringes and needles]","year":"2006"},{"key":"B34","volume-title":"[National Board of Health and Welfare]. SFS 2017:7. Lag om \u00c4ndring I Lagen (2006:323) om Utbyte av Sprutor Och Kanyler [Act (SFS 2017:7) Amending Code of Statues (2006: 323) Regulating Exchange of Syringes and Needles]","year":"2017"},{"key":"B35","volume-title":"[National Board of Health and Welfare]. HSLF-FS 2016:1. Socialstyrelsens F\u00f6reskrifter Och Allm\u00e4nna R\u00e5d Om L\u00e4kemedelsassisterad Behandling Vid Opioidberoende [Code of statutes (HSLF-FS 2016:1) regulating opioid substitution treatment]","year":"2016"},{"key":"B36","volume-title":"[National Board of Health and Welfare]. Tillg\u00e4ngligg\u00f6ra Naloxon f\u00f6r Patienter Och Personer Utanf\u00f6r H\u00e4lso- Och Sjukv\u00e5rden. [Making naloxone available for patients and individuals outside of healthcare]","year":"2017"},{"key":"B37","volume-title":"[National Board of Health and Welfare]. HSLF-FS 2018:43. Om Beh\u00f6righet f\u00f6r Sjuksk\u00f6terskor Att F\u00f6rskriva Och Ordinera L\u00e4kemedel. [Code of statutes (HSLF-FS 2018:43) regulating registered nurses' competence in prescribing drugs]","year":"2018"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"B39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12888-020-2470-3","article-title":"Protocol for a multi-site study of the effects of overdose prevention education with naloxone distribution program in Sk\u00e5ne County, Sweden","volume":"20","author":"Troberg","year":"2020","journal-title":"BMC Psychiatry."},{"key":"B40","volume-title":"SPSS version 27.0. IBM Corp. Released. IBM SPSS Statistics for Windows, Version 27.0","year":"2020"},{"key":"B41","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11524-010-9495-8","article-title":"Overdose prevention and naloxone prescription for opioid users in San Francisco","volume":"87","author":"Enteen","year":"2010","journal-title":"J Urban Health."},{"key":"B42","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.9778\/cmajo.20140008","article-title":"A quantitative and qualitative evaluation of the british columbia take home naloxone program","volume":"2","author":"Banjo","year":"2014","journal-title":"CMAJ open."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e200117","DOI":"10.1001\/jamanetworkopen.2020.0117","article-title":"Association of take-home naloxone and opioid overdose reversals performed by patients in an opioid treatment program","volume":"3","author":"Katzman","year":"2020","journal-title":"JAMA Network Open."},{"key":"B44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drugalcdep.2016.12.013","article-title":"Rapid widespread distribution of intranasal naloxone for overdose prevention","volume":"173","author":"Madah-Amiri","year":"2017","journal-title":"Drug Alcohol Dep."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e0238618","DOI":"10.1371\/journal.pone.0238618","article-title":"Accessing take-home naloxone in British Columbia and the role of community pharmacies: results from the analysis of administrative data","volume":"15","author":"Moustaqim-Barrette","year":"2020","journal-title":"PLoS ONE."},{"key":"B46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1360-0443.2005.00975.x","article-title":"Calling emergency medical services during drug overdose: an examination of individual, social and setting correlates","volume":"100","author":"Tobin","year":"2005","journal-title":"Addiction."},{"key":"B47","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1471-2458-14-297","article-title":"Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study","volume":"14","author":"Doe-Simkins","year":"2014","journal-title":"BMC Public Health."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s11524-011-9600-7","article-title":"Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania","volume":"88","author":"Bennett","year":"2011","journal-title":"J Urban Health."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e011224","DOI":"10.1136\/bmjopen-2016-011224","article-title":"Predictors of seeking emergency medical help during overdose events in a provincial naloxone distribution programme: a retrospective analysis","volume":"6","author":"Ambrose","year":"2016","journal-title":"BMJ Open."},{"key":"B50","doi-asserted-by":"publisher","first-page":"107531","DOI":"10.1016\/j.drugalcdep.2019.06.033","article-title":"Factors associated with help seeking by community responders trained in overdose prevention and naloxone administration in Massachusetts","volume":"204","author":"Lim","year":"2019","journal-title":"Drug Alcohol Dep."},{"key":"B51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.18043\/ncm.79.3.149","article-title":"Facilitators and barriers to naloxone kit use among opioid-dependent patients enrolled in medication assisted therapy clinics in North Carolina","volume":"79","author":"Khatiwoda","year":"2018","journal-title":"North Carolina Med J."},{"key":"B52","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10900-012-9591-7","article-title":"Injection drug users trained by overdose prevention programs: responses to witnessed overdoses","volume":"38","author":"Lankenau","year":"2013","journal-title":"J Community Health."},{"key":"B53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/add.13602","article-title":"Evaluating the impact of a national naloxone programme on ambulance attendance at overdose incidents: a controlled time-series analysis","volume":"112","author":"McAuley","year":"2017","journal-title":"Addiction."},{"key":"B54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.drugpo.2019.07.038","article-title":"Narratives of people who inject drugs on factors contributing to opioid overdose","volume":"74","author":"Chang","year":"2019","journal-title":"Int J Drug Policy."},{"key":"B55","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.drugpo.2017.06.008","article-title":"Why are some people who have received overdose education and naloxone reticent to call emergency medical services in the event of overdose?","volume":"48","author":"Koester","year":"2017","journal-title":"Int J Drug Policy."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0223823","DOI":"10.1371\/journal.pone.0223823","article-title":"Post-overdose interventions triggered by calling 911: centering the perspectives of people who use drugs (PWUDs)","volume":"14","author":"Wagner","year":"2019","journal-title":"PLoS ONE."},{"key":"B57","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.amepre.2006.04.002","article-title":"Response to overdose among injection drug users","volume":"31","author":"Pollini","year":"2006","journal-title":"Am J Prev Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.drugpo.2018.05.002","article-title":"\u201cOnce I'd done it once it was like writing your name\u201d: lived experience of take-home naloxone administration by people who inject drugs","volume":"58","author":"McAuley","year":"2018","journal-title":"Int J Drug Policy"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.811001\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T10:15:19Z","timestamp":1646907319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.811001\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":58,"alternative-id":["10.3389\/fpubh.2022.811001"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.811001","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"811001"}}